Abstract. cAMP response-element binding protein (CREB) functions in hippocampal synaptic plasticity and memory formation. However, it remains unknown whether intravenous anesthetics modulate CREB. The present study aimed to examine the effects of intravenous anesthetics on CREB phosphorylation in the mouse hippocampus. CREB phosphorylation was examined in hippocampal slices with and without pharmacological or intravenous anesthetics via immunoblotting. In a dose-response experiment, the concentrations of intravenous anesthetics ranged from 10 -9 to 10 -4 mol/l for 1 h. For the time-response experiment, these slices were incubated with 5x10 -6 mol/l of propofol for 0, 1, 2, 5, 7, 9, 12, 15, 30 and 60 min. In order to examine whether CREB phosphorylation could be recovered following washing out the propofol, the slices were incubated in plain artificial cerebrospinal fluid at different time durations following 5 min incubation with propofol. Propofol, etomidate, ketamine and midazolam inhibited CREB phosphorylation (P<0.05) in a time-and dose-dependent manner. This inhibition was reversible following the removal of propofol, and was rescued by CREB phosphorylation (P<0.05). The decrease in CREB phosphorylation revealed additive effects with 100 µM of chelerythrine and 20 µM of PD-98059, and the etomidate-induced decrease in CREB phosphorylation was blocked by 1 mM of NMDA. However, 0.1 µM of phorbol 12-myristate 13-acetate, 50 µM of U 73122, 100 µM of carbachol and 10 µM of MK801 were ineffective in the anesthetic-induced decrease in CREB phosphorylation. Intravenous anesthetics markedly decreased CREB phosphorylation in the mouse hippocampus, which was most likely via the protein kinase C and mitogen activated protein kinase pathways. This suggests that CREB represents a target for anesthetic action in the brain.
Introduction
Postoperative cognitive dysfunction (POCD) is the deterioration of cognitive performance after anesthesia (and/or surgery), which presents as impaired memory or concentration (1) . Its clinical features include deterioration in cognition, disturbance in attention and reduced awareness of the environment, which result in higher morbidity, mortality and greater utilization of social financial assistance. Aging societies can expect an increase in the incidence of POCD (2) . POCD is a decrease in cognition measured by neuropsychological tests after anesthesia and surgery (3) . In some studies, the incidence of POCD has reached as high as 26% (4) . Furthermore, at seven days after surgery with propofol anesthesia, the incidence of POCD was 29.7% (5) .
It has been considered that cAMP response-element binding protein (CREB) functions in hippocampal synaptic plasticity and hippocampus-dependent long-term memory (6) . CREB modulates the transcription of genes, which contain a cAMP responsive element (CRE sites) in their promoters, and appears to represent a key molecule in transforming incoming information into long-term memory (7) . Agents that disrupt the activity of CREB specifically block the formation of long-term memory (8) . A number of neurotransmitter receptors and signaling pathways, such as protein kinase C (PKC), phospholipase C (PLC), N-Methyl-D-Aspartate (NMDA) receptors and MAPK/ERK kinase (MEK), contribute to transcriptional activation, and these receptors are coupled to CREB activation through mitogen-activated protein kinase (MAPK) (Fig. 1) (9) . The dysregulation of CREB activation and cross-talking among relevant receptor pathways may be responsible for the effects of intravenous anesthetics on cognition.
It has been previously reported that ketamine suppresses not only the morphine-induced phosphorylation of CREB, but also the residue preference (10) . A sub-anaesthetic dose of Effects of intravenous anesthetics on the phosphorylation of cAMP response element-binding protein in hippocampal slices of adult mice propofol causes impairment of spatial memory retention, but not acquisition inability, which was possibly mediated by the inhibition of CREB signaling (11) . CREB may be the common target of anesthetics. The effects of intravenous anesthetics on CREB phosphorylation in hippocampal slices have not yet been studied. CREB phosphorylation studies offer the opportunity to examine potential mechanisms that contribute to POCD. We hypothesize that anesthesia might cause memory impairment by inhibiting the phosphorylation of hippocampal CREB. Previous studies have shown that CREB plays a key role in hippocampal synaptic plasticity and memory formation. However, its role in POCD remains to be determined.
Materials and methods
Handling procedures were made according to the Guide for the Care and Use of Laboratory Animals. A total of 72 BALB/C mice (both sex, weight: 18-22 g; Capital University of Medical Science, Beijing, China) were used to perform the experiments. Mice were housed on a 12:12 light/dark cycle, with food and water ad libitum. The experimental protocol was approved by the Institutional Animal Care and Use Committee of the Capital University of Medical Science.
Preparation of hippocampal slices and homogenates.
Animals were sacrificed by decapitation. The brains were quickly removed, and the hemispheres were separated. Each hippocampi was carefully dissected and incubated in Ca 2+ -free artificial cerebrospinal fluid (aCSF) [4˚C, 116 mM of NaCl, 26.2 mM of NaHCO 3 , 5.4 mM of KCl, 0.9 mM of NaH 2 PO 4 and 5.6 mM of glucose adjusted to pH 7.4, with 95%/5% (vol/vol) oxygen-carbon dioxide mixture].
The hippocampal slices (at a thickness of 450 µm) prepared using a McIlwain tissue chopper (Campden Instruments Ltd., Loughborough, UK), transferred onto a six-well plate, and added with 10 ml/well of aCSF (eight slices per well). The hippocampal slices were allowed to stabilize for one hour under room temperature. The diffusion of etomidate into the brain slices requires approximately an hour to reach 80% equilibration at a depth of 100 micromillimeters (12) .
Slices were slowly warmed to 37˚C and allowed to equilibrate for 60 min without stimulation until pharmacologic treatment. The aCSF in the chamber was maintained at 37˚C for the experiment.
At the end of the experiments, cerebrospinal fluid was aspirated, and the slices were frozen in liquid nitrogen. The tissues were homogenized by sonication in 100 µl of ice-cold homogenization buffer, which consisted of 50 mM of Tris-HCL (pH 7.5), 1 mM of sodium orthovanadate, 2 mM of ethylenediaminetetraacetic acid, 2 mM of ethylene glycol tetraacetic acid, 1 mM of dithiothreitol, 5 mM of sodium pyrophosphate, 5 mM of potassium fluoride, 100 nM of okadaic acid, 0.5% IGEPAL CA-630 (Np-40), and protease inhibitors (5 µg/ml of leupeptin, 5 µg/ml of aprotinin, 5 µg/ml of pepstatin and 5 µg/ml of chymostatin), and boiled for five min. The homogenates were stored at -70˚C until processing.
Chemicals and anesthetics. The effects of the following pharmacological and anesthetic agents on CR EB phosphorylation were studied alone or in combination with the following agents: Propofol (1 nM-100 µM; AstraZeneca, London, UK), etomidate (1 nM-100 µM; Enhua Pharmaceuticals, Xuzhou, China), ketamine (1 nM-100 µM; SBPC, Shanghai, China), midazolam (1 nM-100 µM; Roche, Basel, Switzerland), NMDA (1 mM; Sigma, St. Louis, MO), MK801 (10 µM; Sigma), chelerythrine (an inhibitor of PKC, 100 µM, Merck, Kenilworth, NJ), phorbol 12-myristate 13-acetate (PMA, an activator of PKC, 0.1 µM; Sigma), carbachol [100 µM, an activator of PLC; Sigma], U73122 (50 µM, an inhibitor of PLC; Sigma), and PD 98059 (20 µM, an inhibitor of MEK; Sigma). Anesthetics were applied for 60 min, while chelerythrine, PMA, carbachol, U73122, MK801, NMDA and PD 98059 were pre-incubated for one hour before adding any other anesthetics.
In the time-response experiment, hippocampi in one group was continuously exposed to 5 µM of propofol for 1, 2, 5, 7, 9, 12, 15, 30 and 60 min, respectively, while hippocampi in the other group was incubated for five min only, and washed thoroughly with plain aCSF for 2, 4, 7, 10 and 25 min, respectively, in order to determine the recovery of CREB phosphorylation.
Immunoblot analysis. Protein concentration in the homogenates was determined by bicinchoninic acid-based assay using bovine serum albumin as a standard. Equal amounts of protein (50 µg) were separated on 10% polyacrylamide gel in the presence of sodium dodecyl sulphate, and transferred onto nitrocellulose membranes (Bio-Rad Laboratories, Inc.,, Hercules, CA, USA). The blots were blocked with 10% non-fat dried milk in phosphate buffered saline with 0.1% Tween-20 for one hour at room temperature with agitation. Then, the membranes were incubated with rabbit anti-phosphor-CREB antibody (1:800; Cell Signaling Technology, Beverly, MA, USA) at 4˚C overnight. Next, horseradish peroxidase-conjugated anti-rabbit IgG (Chemicon, Temecula, CA, USA) was used at a dilation of 1:5,000 and the immune complex was detected by enhanced chemiluminescence western blotting detection reagents (Chemicon). In order to determine the percentage of phosphorylated CREB, the membranes were stripped and incubated with rabbit anti-CREB antibody (1:800; Cell Signaling Technology), and processed, as aforementioned. Immunoreactive bands were quantified using a computer-assisted densitometer, and expressed as a ratio between active CREB signal and total CREB.
Statistical analysis. Statistical analysis was performed on raw data using one-way analyses of variance (ANOVA), and statistical differences between the control and experimental groups were determined using the least significant difference procedure for multiple comparisons. P<0.05 was considered to indicate a statistically significant difference. Data (mean ± standard deviation) were normalized against the P-CREB/total-CREB ratio of the controls.
Results

Propofol, etomidate, ketamine and midazolam inhibited the phosphorylation of CREB.
In order to evaluate the effects of propofol, etomidate, ketamine and midazolam on the phosphorylation of CREB, western blot analysis was performed on the hippocampus slices exposed to a range of doses of individual drugs. The anesthetics used at these concentrations markedly reduced the phosphorylation of CREB at Ser133 in a dose-dependent manner (Fig. 2) .
Next, it was determined whether the inhibition of CREB phosphorylation by anesthetics was reversible using propofol, which is a most commonly used intravenous anesthetic. One group of hippocampi were continuously exposed to 5 µM of propofol for 1, 2, 5, 7, 9, 12, 15, 30 and 60 min, while the other group was challenged for five min only. These were thoroughly washed and analyzed in parallel for CREB phosphorylation. In these results, exposure to 5 µM of propofol induced a reduction in CREB phosphorylation, which proportionally decreased with exposure time. Therefore, a 60-minute exposure to stimulating agents was selected for further experiments. In contrast, the removal of propofol after five min of exposure resulted in the recovery of CREB phosphorylation starting from the seven-minute time point (Fig. 3) .
Previous studies have demonstrated the involvement of kinase receptor pathways in the interference with cognition by intravenous anesthetics (13) . Therefore, the agonists and antagonists of PKC, PLC, MEK and NMDA receptors were used in this study to characterize the functional importance of individual pathways. The inhibition of PKC by chelerythrine (100 µM) resulted in a 50.3% decrease in CREB phosphorylation (P<0.05), and revealed the additive effects of the anesthetic-induced decrease in CREB phosphorylation (Fig. 4) . The activation of PKC by PMA (0.1 µM) induced a 65.9% decrease in CREB phosphorylation (P<0.05), showing no effects on the anesthetic-induced decrease in CREB phosphorylation (data not shown).
NMDA (1 mM) induced a weak but not significant reduction in CREB phosphorylation (Fig. 5) . This completely blocked the etomidate-induced decrease in CREB phosphorylation, but only partially suppressed the effects of other anesthetic agents (Fig. 5) .
In contrast, an NMDA receptor antagonist, MK801 (10 µM), was ineffective in blocking the anesthetic-induced decrease in CREB phosphorylation. Moreover, the inhibition of PLC by U 73122 (50 µM) and the activation of PLC by carbachol (100 µM) also had no effects on the anesthetic-induced suppression of CREB phosphorylation. PD-98059 (an inhibitor of MEK, 20 µM) induced a significant decrease in CREB phosphorylation by 43.7% (P<0.05), and revealed an additive or synergistic influence on the propofol-and a ketamine-induced decrease in CREB phosphorylation (Fig. 6) .
Discussion
In the present study, it was shown that clinically relevant concentrations of intravenous anesthetic agents decreased the phosphorylation of CREB in mice hippocampal slices. These effects are likely to be mediated indirectly via the NMDA receptor, PKC and MAPK/ERK signaling pathways. These present findings support the notion that the phosphorylation of CREB represents a target for anesthetic action in the central nervous system.
Cognitive side-effects such as emergence agitation (EA), postoperative delirium (POD) and POCD do not infrequently complicate postoperative care, especially in elderly and fragile patients (14) . POCD is a recognized clinical entity characterized with cognitive deficits after anesthesia and surgery, especially in elderly patients (15) .
Recent evidence has indicated that propofol and midazolam impair memory for aversive and non-aversive experiences at equianxiolytic doses that do not produce locomotor impairment in rats (16) . In humans, ketamine selectively affects working, episodic and procedural memory, but not perceptual priming, attention, or executive functioning. 9 These findings suggest that intravenous anesthetics disrupt memory formation, and may potentially suppress the activity of transcription regulators that are considered to contribute to memory processing. Transcriptional factor CREB is activated in spatial learning (17) . The radial maze training in rats increases CREB phosphorylation in the hippocampus in the course of spatial learning, which is followed by spatial memory formation (17) . Furthermore, CREB is an evolutionarily conserved transcription regulator essential for long-term memory formation (18) , and plays a critical role in long-term memory in invertebrates and vertebrates (19) . In the present experiments, it was observed that all intravenous anesthetic agents inhibited CREB phosphorylation in proportion to dosages. This inhibitory effect on CREB phosphorylation in the hippocampus coincided with the amnestic effects of anesthetics in clinical practice. We also observed the reversibility of these anesthetic effects on CREB phosphorylation, at least for propofol, although the direct extrapolation to all anesthetics could not be made. The lack of desensitization of its effects over time and the reversibility of the propofol-induced inhibition of CREB phosphorylation further support the relevance of these present findings to anesthesia.
CREB is a vital part of many intracellular signaling events that regulate multiple neural functions. Human recombinant CREB can be phosphorylated by cAMP-dependent protein kinase and PKC in vitro (20) , but preferentially at distinct serine residues. Two serines located in the basic region of CREB, Ser-340 and Ser-367, are the major PKC phosphorylation sites (20) .
It has been previously shown that CREB phosphorylation is pr i ncipa l ly reg u lat e d by PKC i n i m mat u re oligodendrocytes (21) , and the inhibition of PKC blocks the retinoic acid-mediated activation of CREB (22) . The PKC family consists of several members, which can be divided into three major groups: Classical PKC (α, βI, βII and γ), novel PKC (δ, ε, η and θ), and atypical PKC (ζ and ι/λ) (23) . GF 109203X inhibited the conventional isoforms and novel isoforms of PKC (24, 25) . A significant decrease in CREB phosphorylation was also observed with the pre-treatment of 1 µM of GF 109203X, indicating that the conventional and novel isoforms of PKC are responsible for CREB phosphorylation after OX2R activation in CHO cells (26) . The phosphorylation of CREB at serine-133 induced by signaling through the B-cell antigen receptor requires PKCδ (27) . PKCε is implicated in cytokine-induced serine-133 phosphorylation and the activation of CREB-mediated transcription in human erythroleukemia cell line TF-1. However, PKCε forms a component of the signal cascade rather than act as the genuine CREB kinase (28) . Chelerythrine is also a large spectrum PKC inhibitor.
Furthermore, the apparent additive effect of PKC inhibitor chelerythrine was observed on the anesthetic-induced inhibition of CREB phosphorylation, while PKC activation by PMA revealed no obvious changes. These results suggest that PKC is responsible for the anesthetic-induced decrease in CREB phosphorylation at Ser133, while its activation had no effect. The phosphorylation of platelet protein P47, which is a marker of PKC activation, is markedly inhibited by ketamine (350 µM) or midazolam (15 and 30 µM) (29, 30) , and there is little direct evidence on the effect of intravenous anesthetics on PKC.
Behavioral, anatomical and electrophysiological studies have shown that hippocampal NMDA receptors are involved in human memory (31) . NMDA stimulation induces the rapid phosphorylation of CREB on Ser133 during the development of hippocampal neurons in culture (32) . The activation of NMDA receptors by NMDA rapidly and concentration-dependently increases the number of neurons expressing phosphorylated CREB, while antagonizing NMDA signaling by MK801 reduces CREB phosphorylation (33) . In addition, the transcription of NMDAR1 is regulated by the c-AMP signaling pathway, which is most likely through the binding of CREB and its activation through signal-dependent phosphorylation (34) . It is now clear that neither AMPA/kainate receptors, nor NMDA receptors are sufficient to independently stimulate a second messenger pathway that leads to CREB phosphorylation (35) . In the present study, it was observed that NMDA treatment induced a weak but not significant decrease in CREB phosphorylation. The NMDA treatment itself did not increase CREB phosphorylation in the present experiment. It was reported that an increase in p-CREB protein level was observed from 6-12 h after NMDA injection in the retina (36) . Moreover, CREB phosphorylation after exposure to glutamate was shown to be dependent on CaMK II/IV in hippocampal neurons (37) . However, this completely blocked the etomidate-induced decrease in CREB phosphorylation, and partially blocked the inhibition of other anesthetic agents. Lipid emulsions have been used as carriers for hypnotics such as propofol and etomidate. Lipid emulsions activate NMDA receptor channels in cortical neurons (38) . It channels (39) . The MAPK pathway is another signaling cascade that regulates CREB (39) . MAPK activation is required for the phosphorylation of CREB in response to the activation of PKC, and is needed for PKA coupling to CREB phosphorylation in the CA1 area (34) . Furthermore, activated MAPK increases the phosphorylation of CREB by stimulating its gene expression (40) . Hence, the inhibition of ERK1/2 by PD98059 reduces CREB phosphorylation (41) . It was observed that PD-98059 induced a significant decrease in CREB phosphorylation, and revealed its additive influence on the propofol-and ketamine-induced decrease in CREB phosphorylation. These results indicate that intravenous anesthetic agents may induce a decrease in CREB phosphorylation via the ERK1/2 signal transduction pathway. Propofol, midazolam and etomidate act at GABAA receptors, and ketamine act at NMDA receptors. The enhancement of GABAA receptor-mediated inhibition is a property of most general anesthetics, which is a candidate for the molecular mechanism of anesthesia (42, 43) . Ketamine is an NMDA receptor antagonist anesthetic agent (44) . Since GABAA is not related to MAPK-CREB, a GABA (A) agonist and antagonist experiment was not performed.
Taken together, clinically relevant concentrations of intravenous anesthetic agents decrease the phosphorylation of CREB in mice hippocampal slices. These effects are likely to be mediated indirectly via the NMDA receptor, PKC and ERK1/2 signaling pathways. These findings support the idea that these inhibitory effects on CREB phosphorylation may be potential mechanisms that contribute to anesthetic-induced amnesia.
